Tetradecane

Tetradecane

SCHEMBL4332025

CCCCCCCCCCCCCC.O=C(O)CO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.65
PPARG P37231 7/20 0.65
PPARD Q03181 7/20 0.65
PPARA Q07869 7/20 0.65
HDAC11 Q96DB2 5/20 0.65
TSHR P16473 5/20 0.65
PTPN1 P18031 3/20 0.65
ALDH1A1 P00352 3/20 0.65
KMT2A Q03164 3/20 0.65
TLR2 O60603 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
FABP4 P15090 2/20 0.65
MEN1 O00255 2/20 0.65
HSD17B10 Q99714 2/20 0.65
SLC22A6 Q4U2R8 1/20 0.65
SLC22A8 Q8TCC7 1/20 0.65
ESR1 P03372 1/20 0.65
ALOX15 P16050 1/20 0.65
PDE4A P27815 1/20 0.65
PDE3A Q14432 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptane SCHEMBL28087513 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Decane SCHEMBL4332022 1.00 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11
Hexane SCHEMBL5595400 0.97 AKR1B1 (0.63) GPR84PPARGPPARDPPARAHDAC11
Hexane SCHEMBL28927850 0.97 AKR1B1 (0.63) GPR84PPARGPPARDPPARAHDAC11
Dodecanol SCHEMBL23364909 0.92 TSHR (0.68) GPR84PPARGPPARDPPARAHDAC11
Docosanol SCHEMBL28822935 0.92 TSHR (0.68) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL2116876 0.89 GPR84 (0.85) GPR84PPARGPPARDPPARAHDAC11
Myristyl Alcohol SCHEMBL29391910 0.89 TSHR (0.65) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL2118104 0.87 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Dodecylamine SCHEMBL9701555 0.87 DNM1 (0.62) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582436-B2 3′ end tagged oligonucleotides THIRD WAVE TECHNOLOGIES, INC. (US) 2009-09-01 US disclosed
US-20080293930-A1 3' end tagged oligonucleotides CYTYC CORPORATION 2008-11-27 US disclosed
US-20080015349-A1 Oligonucleotide production THIRD WAVE TECHNOLOGIES, INC. (US) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015349-A1 Oligonucleotide production RNGTT, DCLRE1B, RNMT GPR84 2324/4885PPARG 4384/4885PPARD 4309/4885
US-20080293930-A1 3' end tagged oligonucleotides DCLRE1B, NUDT21, CPSF6 GPR84 3060/4885PPARG 4551/4885PPARD 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.